Navigation Links
Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
Date:4/22/2013

. The 2013 conference program features a truly thought-leading presenter line-up and influential decision-makers from FDA/CDRH, Stryker, Medtronic Spine, Biomet, Zimmer, Depuy Synthes, OrthoSensor, Orthogen, Cook BioTech, Case Western Reserve University, GHX, MED Institute and others.

To learn more about the conference program and the 2013 speaker line-up, visit http://www.orthotecshow.com 

The OrthoTec Conference and Exhibition is well-attended annually by colleagues from Biomet, DePuy Synthes, Zimmer, Medtronic Spinal & Biologics, Stryker, Tornier, OrthoPediatrics, Symmetry Medical, Paragon Medical, and more.  See here for a full list of attending companies. Qualified professionals will receive complimentary admission to the event. OrthoTec 2013 is sponsored by Solvay Plastics.

About UBM Canon-Organizer of OrthoTec

UBM Canon LLC, the leading B2B media company dedicated exclusively to the global $3 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

Sponsorship Opportunities:
sponsorship@ubm.com  
+1-310-996-9435


Conference Program:
Vu Nguyen
+1-310-996-9495
Vu.Nguyen@ubm.com


Marketing Contact:
Kelly Ryan
+1-310-445-8516

SOURCE UBM Conferences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
2. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
3. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
4. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
5. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
6. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
7. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
8. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
9. American Management Association Teams With Biogen Idec To Create Life Skills Workshops For People Living With Hemophilia
10. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
11. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... and RARITAN, N.J. , May ... open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial ... human anti-CD38 monoclonal antibody – achieved an overall ... 20.8-38.9), as assessed by an independent review committee, ... ORR was consistent among the pre-specified subgroups based ...
(Date:5/29/2015)... Norway , May 29, 2015 ... biopharmaceutical company, today announces that an abstract on the ... molecule inhibitor of the Axl receptor tyrosine kinase, and ... at BerGenBio, has been published in conjunction with the ... in Chicago , May 29 - ...
(Date:5/29/2015)... Market Publishers Ltd and Shanghai ... partnership agreement for quality market research promotion on ... sell research reports worked out by Chem-Report. , ... upon the agreement: “Chem-Report is a Chinese company ... chemical markets on global and country levels. The ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences ® ... the promise of precision medicine, today announced the ... the clinical utility of Caris Molecular Intelligence ® ... in helping to identify targeted treatment options for ... of the studies, results of which are to ...
Breaking Biology Technology:Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6
... Cynvec LLC, a privately held biotechnology company focused ... ability of the sindbis viral vector, today announced that ... a presentation titled "Cynvec: Breakthrough Oncolytic Viral Vector Therapy ... on Biotechnology and Pharmaceutical Industry. Mr. Stonebanks, presentation ...
... Pharmaceuticals, a pioneer in the development of novel products ... disease, announced that it has promoted F. Stephen Laroux, ... inflammatory diseases, effective immediately. Dr. Laroux joined the company ... team of Cequent researchers developing drug candidates using Cequent,s ...
... LLC announced today that it has issued an Executive Informational ... full 56-page report can be found at www.crystalra.com ... Company") is a development-stage biotechnology company focused on the discovery ... inactive precursor of a drug that is converted into its ...
Cached Biology Technology:Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 2Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc. 3
(Date:5/8/2015)... Calif. , May 8, 2015 Synaptics Inc. ... solutions, today announced that members of the executive management team ... Morgan 43rd Annual Technology, Media and Telecom Conference Date: ... Hotel in Boston, MA ... 27, 2015 Time: 2:45pm ET Location: The New York Palace ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... catch more than a cold from certain viruses. Some ... their insides to soup - without harming beneficial insects ... environmentally friendly means of biological crop protection worldwide. The ... has been controlled in European orchards for years with ...
... of the worlds worst pollution problems of the 1970s and ... Europe and North America. In Wales, more than 12,000 ... stream insects and river birds such as the dipper. ... Europe to clean up acid pollutants from power generation and ...
... States participating in the GMES Programme approved the transition ... Component Programme. Oversubscription of the programme by the ... with oversubscription to phase 2 of 116%, giving a ... the programme will allow ESA to confirm the development ...
Cached Biology News:Surprise in the organic orchard -- a healthier worm in the apple 2Recovery from acid rain 'much slower than expected' 2
... Rabbit polyclonal to MLF1 Interacting ... for all tested applications). ... corresponding to amino acids 73-83 of ... Entrez Gene ID: 359815 ...
... Nuclease is a genetically engineered endonuclease. This ... and RNA while having no proteolytic activity. ... of conditions and possesses an exceptionally high ... acids from recombinant proteins, its use enables ...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Rice microRNA Microarray ...
Biology Products: